SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

MGM Resorts International is a holding company, which engages in the ownership and operations of casino resorts. The firm's casino resorts offer gaming, hotel, convention, dining, entertainment, retail, and other resort amenities. It operates through the following business segments: Las Vegas Strip Resorts, Regional Operations, MGM China, and MGM Digital. The Las Vegas Strip Resorts segment operates the following casino resorts: Bellagio, MGM Grand Las Vegas, Mandalay Bay, The Mirage, Luxor, New York-New, Excalibur, Park MGM, and Circus Las Vegas. The Regional Operations segment consists of the following casino resorts: MGM Grand Detroit in Detroit, Michigan, Beau Rivage in Biloxi, Mississippi, Gold Strike Tunica in Tunica, Mississippi, Borgata in Atlantic City, New Jersey, MGM National Harbor in Prince George’s County, Maryland, and MGM Springfield in Springfield, Massachusetts. The MGM China segment includes MGM Macau and MGM Cotai. The MGM Digital segment focuses on the online gaming portfolio, which consists primarily of Leo Vegas, which is headquartered in Sweden and Malta. The company was founded by Kerkor Kerkorian on January 29, 1986 and is headquartered in Las Vegas, NV.

MGM Resorts International

Director Keith Meisters substantial open-market purchase is fueling bullish interest, with some traders speculating it signals a possible takeover. Others caution that the buy does not confirm a deal and argue it may simply reflect confidence in the stock after its decline.

Zoom Communications, Inc. engages in the provision of a communications and collaboration platform. It operates through the following geographical segments: Americas, Asia Pacific, and Europe, Middle East, and Africa. The company was founded by Eric S. Yuan in 2011 and is headquartered in San Jose, CA.

Zoom Communications Inc. - Ordinary Shares - Class A

Zooms Anthropic investment is drawing attention as traders treat the company as a public-market proxy amid IPO and valuation speculation. Bulls see the stake as potential upside alongside Zooms AI push, while skeptics argue it does not resolve modest core-business growth and competition from bundled platforms.

Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of therapeutics for metabolic dysfunction-associated steatohepatitis. The company was founded by Rebecca A. Taub, Frederick Bernard Craves, and Edward Chiang on March 10, 2000 and is headquartered in West Conshohocken, PA.

Madrigal Pharmaceuticals Inc

A former clinical-development executives whistleblower lawsuit alleging problems with Madrigals safety reporting and clinical data is driving debate; the claims are unproven and the company disputes them. Traders are weighing that overhang and concerns about near-term profitability against strong Rezdiffra growth and the companys first profitable quarter, with reactions split between buying the selloff and fearing further downside.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

NASAs CLPS 2.0 selection has sparked attention, with traders debating the potential for future lunar-delivery work and whether the announcement represents specific contract awards or only eligibility to compete. The community cheered the sharp rally, while some cautioned that the selection does not guarantee missions or revenue.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sareptas quarterly update has traders weighing strong PMO performance and a higher revenue outlook against subdued ELEVIDYS sales and uncertainty over restoring broader access. Discussion also centers on upcoming DM1 and FSHD data, which bulls see as a potential pipeline catalyst while skeptics caution that results remain unproven.

Ouster, Inc. engages in the provision of high resolution digital lidar sensors that offer advanced 3D vision to machinery, vehicles, robots, and fixed infrastructure assets. The company was founded by Angus Pacala and Mark Frichtl on June 30, 2015 and is headquartered in San Francisco, CA.

Ouster Inc - Ordinary Shares - Class A

Ousters quarterly results and Q4 outlook are drawing attention, with traders citing stronger-than-expected growth, record sensor shipments and narrowing losses. Many see the results as supporting its lidar, camera and robotics/Physical AI growth story, while others question the valuation and margins or point to broader pressure on AI-linked stocks.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

A wave of analyst downgrades after UiPaths investor event has intensified concerns about slowing growth, customer pushback on AI pricing, and whether its agentic-AI products can accelerate recurring revenue. Bulls see the selloff as overdone and argue UiPaths orchestration platform is well positioned for enterprise AI, while skeptics want stronger evidence of monetization.

Snowflake, Inc. engages in the provision of cloud data warehousing software. The firm offers Data Cloud, an ecosystem where Snowflake customers, partners, data providers, and data consumers can break down data silos and derive value from data. Its platform supports a range of use cases including data warehousing, data lakes, data engineering, data science, data application development, and data sharing. The cloud-native architecture consists of layers across storage, compute, and cloud services. The storage layer ingests structured and semi-structured data to create a unified data record. The compute layer provides dedicated resources to enable users to access common data sets for many use cases without latency. The cloud services layer optimizes each use case's performance requirements with no administration. The company was founded by Marcin Zukowski, Thierry Cruanes, and Benoit Dageville on July 23, 2012 and is headquartered in Menlo Park, CA.

Snowflake Inc

Concerns that Snowflakes consumption-based revenue could weaken as customers cut queries, AI workloads, and storage use amid tighter budgets dominate the discussion. Traders are divided, with some viewing the recent bounce and call activity as a buying opportunity while others focus on downside risk and the stocks reliance on sustained usage growth.

Okta, Inc. engages in the provision of an identity management platform for enterprises. The firm operates through the following geographical segments: United States and International. Its products include single sign-on, multi-factor authentication, access gateway, API access management, authentication, adaptive MFA and lifecycle management. The company was founded by Todd McKinnon and J. Frederic Kerrest in 2009 and is headquartered in San Francisco, CA.

Okta Inc - Ordinary Shares - Class A

Okta Inc

OKTA is drawing attention after a sharp pullback alongside put-heavy options activity, with traders debating whether the selling reflects bearish positioning or hedging. The broader debate pits concerns that layoffs and tighter budgets could shrink per-user identity-software demand against the bullish view that AI agents will create new identity-security needs.

Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib, which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia, KO-947, which is an ERK inhibitor for MAPK Pathway Tumors, and KO-539, which is a Menin MLL inhibitor for acute leukemias. The company was founded by Troy E. Wilson, Yi Liu, Pingda Ren and Antonio Gualberto on August 22, 2014 and is headquartered in San Diego, CA.

Kura Oncology Inc

Traders are debating whether Johnson & Johnsons bleximenib data pose a competitive threat to Kuras ziftomenib, focusing on how prior venetoclax exposure may skew cross-trial comparisons ahead of further AML data at ASH. Some view the comparison as a reason for the selloff, while others argue ziftomenibs results in exposed patients remain encouraging and that the competitive read-through may be overstated.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


bl555buzz1

BL555